Isolation of efficient antivirals: genetic suppressor elements against HIV-1

被引:12
作者
Dunn, SJ
Park, SW
Sharma, V
Raghu, G
Simone, JM
Tavassoli, R
Young, LM
Ortega, MA
Pan, CH
Alegre, GJ
Roninson, IB
Lipkina, G
Dayn, A
Holzmayer, TA
机构
[1] PPD Discovery Inc, Menlo Park, CA 94025 USA
[2] Ingenex Inc, Menlo Park, CA 94025 USA
[3] Univ Illinois, Dept Mol Genet, Chicago, IL USA
关键词
genetic suppressor elements; HIV; flow cytometry;
D O I
10.1038/sj.gt.3300791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of general approaches for the isolation of efficient antivirals and the identification and validation of targets for drug screening are becoming increasingly important, due to the emergence of previously unrecognized viral diseases. The genetic suppressor element (GSE) technology is an approach based on the functional expression selection of efficient genetic inhibitors from random fragment libraries derived from a gene or genome of interest. We have applied this technology to isolate potent genetic Inhibitors against HIV-1. Two strategies were used to select for GSEs that interfere with latent virus induction and productive HIV-1 infection based on the expression of intracellular and surface antigens. The selected GSEs clustered in seven narrowly defined regions of the HIV-1 genome and were found to be functionally active. These elements are potential candidates for the gene therapy of AIDS. The developed approaches can be applied to other viral pathogens, as well as for the identification of cellular genes supporting the HIV-1 life cycle.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 37 条
[1]   COMPARISON OF TRANSDOMINANT INHIBITORY MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENES EXPRESSED BY RETROVIRAL VECTORS IN HUMAN T-LYMPHOCYTES [J].
BAHNER, I ;
ZHOU, C ;
YU, XJ ;
HAO, QL ;
GUATELLI, JC ;
KOHN, DB .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3199-3207
[2]   GENE-THERAPY - INTRACELLULAR IMMUNIZATION [J].
BALTIMORE, D .
NATURE, 1988, 335 (6189) :395-396
[3]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN HUMAN T-CELLS BY RETROVIRAL-MEDIATED GENE-TRANSFER OF A DOMINANT-NEGATIVE REV TRANSACTIVATOR [J].
BEVEC, D ;
DOBROVNIK, M ;
HAUBER, J ;
BOHNLEIN, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9870-9874
[4]   OSCILLATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS SURFACE-RECEPTOR IS REGULATED BY THE STATE OF VIRAL ACTIVATION IN A CD4+ CELL MODEL OF CHRONIC INFECTION [J].
BUTERA, ST ;
PEREZ, VL ;
WU, BY ;
NABEL, GJ ;
FOLKS, TM .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4645-4653
[5]   Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication [J].
Caputo, A ;
Rossi, C ;
Bozzini, R ;
Betti, M ;
Grossi, MP ;
BarbantiBrodano, G ;
Balboni, PG .
GENE THERAPY, 1997, 4 (04) :288-295
[6]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY RETROVIRAL VECTORS EXPRESSING ANTISENSE-TAR [J].
CHUAH, MKL ;
VANDENDRIESSCHE, T ;
CHANG, HK ;
ENSOLI, B ;
MORGAN, RA .
HUMAN GENE THERAPY, 1994, 5 (12) :1467-1475
[7]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[8]   GENE-THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - GENETIC ANTIVIRAL STRATEGIES AND TARGETS FOR INTERVENTION [J].
DROPULIC, B ;
JEANG, KT .
HUMAN GENE THERAPY, 1994, 5 (08) :927-939
[9]   A MOLECULAR CLONE OF HTLV-III WITH BIOLOGICAL-ACTIVITY [J].
FISHER, AG ;
COLLALTI, E ;
RATNER, L ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1985, 316 (6025) :262-265
[10]   DETECTION OF INTRACELLULAR HIV IN LYMPHOCYTES BY FLOW-CYTOMETRY [J].
GADOL, N ;
CRUTCHER, GJ ;
BUSCH, MP .
CYTOMETRY, 1994, 15 (04) :359-370